Cyclopharm Limited (CYC) is engaged in manufacturing and selling of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector.
There are at least 3m cases of Pulmonary Embolism globally each year. The company sells Technegas generators to radiology departments diagnosing this condition, and, on a recurring basis, the raw material (TN-99) in the form of 50 dose Patient Administration Sets (PAS).
Want to see other interesting ASX Healthcare Shares stocks?
Would you like to invest in CYC?
Get access to all our research on CYC + our current best stocks to buy now. 14 days free. No credit card required just enter your email and you're away.
START YOUR 14 DAY FREE TRIAL
No restrictions, no limits.
Get access to all of Under the Radar Report data FREE for 14 days.
NO CREDIT CARD REQUIRED
JOIN UNDER THE RADAR REPORT
Simply provide your details below to get started.